RSS   Newsletter   Contact   Advertise with us
Post Online Media

Enzymotec appoints Erez Israeli as CEO

EnzymotecEnzymotec, a supplier of specialty lipid-based products and solutions, announced that it has appointed Erez Israeli as president and chief executive officer, effective April 18, 2017.

Mr. Israeli has more than 20 years of experience in strategic planning, business processes, operation, quality, finance and global sales and marketing.

READ MORE Enzymotec announces changes to its board of directors

Mr. Israeli was most recently the President and CEO of Growth Markets at Teva Pharmaceuticals where he oversaw all commercial activities in Asia, Asia Pacific, Africa and Latin America.

Since joining Teva in 1994, Mr. Israeli has held various leadership roles including the Head of Global Quality, President and CEO of Teva API and President, and Group Executive Vice President and Chief Business Process Officer at Teva.

He obtained his MBA in Finance and Marketing from Bar Ilan University, Israel.


 LATEST MOVES FROM Israel 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy